Bayer gains FDA approval for new automated HIV test

Posted on 22 Jun 2006 at 2:10pm
By Associated Press

Company says labs can increase testing with greater accuracy



Drug developer Bayer AG said Wednesday its healthcare diagnostics division received U.S. Food and Drug Administration approval for a new automated HIV test that can detect all known types of the infection.

The test, called the EHIV, or Human Immunodeficiency Virus-Enhanced, was approved for use on Bayer’s ADVIA Centaur Immunoassay System. EHIV is an in vitro diagnostic test that looks for antibodies in human serum and plasma to HIV 1, HIV 2 and a subtype of HIV 1. The test is automated, allowing laboratories to increase testing with more accurate results, Bayer said in a statement.

The system is made and sold by Bayer Diagnostics for Ortho Clinical Diagnostics, a subsidiary of Johnson & Johnson.

American depositary shares of Germany-based Bayer rose 68 cents to $41.61 during morning trading on the New York Stock Exchange. Shares of Johnson & Johnson added 16 cents to $61.69 on the NYSE.

This article appeared in the Dallas Voice print edition, June 23, 2006.

Comments

comments

Powered by Facebook Comments